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EVIDENCE has been presented in recent studies indicating that normal tissue
antigens are deleted as a result of neoplastic change. Whilst antigenic loss has
been demonstrated in both human (Goudie and McCallum, 1962; Nairn et al.,
1962) and experimental tumours (Barch, 1962; Hiramoto, Yagi and Pressman,
1959), the evidence is probably most conclusive from studies with carcinogen
induced liver tumours in rats and mice. Hence Weiler (1956) and Nairn et al.
(1960) using immunohistological procedures have shown that organ specific
antigen of normal rat liver was deleted from tumours induced with 4-dimethyl-
aminoazobenzene (DMAB). Similarly, deletion of liver antigen from a trans-
planted mouse hepatoma has been reported (Engelhardt, Khramkova and Post-
nikova, 1963) whilst Hiramoto, Bernecky, Jurandowski and Pressman (1961)
demonstrated loss of liver microsomal antigen from several transplanted rat
hepatomas as well as 2-acetylaminofluorene induced tumours.
Antigen deletion has also been demonstrated recently by direct immuno-
chemical analysis of tissue fractions. Hence in a series of detailed investigations,
Abelev and his associates (Abelev et al., 1959; Abelev, Khramkova and Post-
nikova, 1962) have demonstrated deletion of organ specific antigens from trans-
planted mouse hepatomas originally induced with o-aminoazotoluene. Further-
more, Kalnins and Stich (1963) and Deckers (1963) have shown loss ofliver antigen
from primary and transplanted rat liver tumours induced with DMAB. There
is thus now considerable evidence indicating that normal liver antigens are lost
from aminoazo dye induced tumour. The studies so far reported, however, have
dealt almost exclusively with changes in microsomal antigens whilst as yet little
attempt has been made to characterize the components that are deleted from
tumour.
In considering the significance of antigenic modification in carcinogenesis,
it is important that the total changes in cell antigen population be clearly defined.
Accordingly in the present investigations, modifications in the antigenic composi-
tion of both microsome and cell sap fractions of rat liver have been determined
and partial characterization ofthe deleted antigens has been obtained by immuno-
electrophoresis. Moreover, these changes have been examined using primary
tumours induced with DMAB, since it is well established from studies on immunity
to transplanted tumours that antigenic modification may occur during trans-
plantation. A preliminary report of these findings has been published (Baldwin,
1963).R. W. BALDWIN
MATERIALS AND METHODS
NYormal rat liver
Normal liver was taken from 3-4 month old male rats of an inbred Wistar
strain which were maintained on a standard cubed diet with water ad libitum.
Arminoazo dye-induced liver tumour
Male Wistar rats, initially 3 months old, were maintained on an unpolished
rice-carrot diet containing 0*06 per cent DMAB for 3 months, and then on the
basal rice diet until tumours developed (4-5 months). Additionally, tumours
were induced with 3'-methyl-DMAB following continuous administration of the
carcinogen at a concentration of 0*075 per cent in a 20 per cent protein diet
(Griffin, Nye, Noda and Luck, 1948) for at least 5 months.
In selecting tissue for study, only well defined, non-necrotic tumour masses
were taken. These were removed following liver perfusion with cold saline and
sucrose solutions, care being taken to exclude gross contamination with liver.
Representative parts of each tumour were fixed in 10 per cent formol saline for
histological examination and the remainder then treated as described later.
Histological examination of tumour sections, kindly undertaken by Professor
(G. J. Cunningham, Royal College of Surgeons, London, showed that the tumours
could be broadly classified into two main types depending upon cellular arrange-
ments. The first type, a typical example of which is illustrated in Fig. 1, was
classified as bile duct carcinoma. In this type of tumour, the main feature was
that of pleomorphic acinar proliferation which was lined in parts by a columnar
type of epithelium, although in general, most of the cells were flattened in shape.
Mitotic figures were numerous. Many ofthe acini contained necrotic cellular debris,
but a few contained mucoid material.
The second type slhowed solid cords of cells with large nuclei and many mitotic
figures often with surrounding zones ofnecrosis and polymorph infiltration (Fig. 2).
Some of these tumours displayed a tendency to acinar formation but this often
was localized and when the main mass oftumour was composed oftightly arranged
cells, they were classified as hepatocellular carcinoma.
In some individual tumours, precise classification into these cell types was
difficult, although in most instances, these two histological appearainces were well
defined.
When transplanted subcutaneously into isogenic hosts, the DMAB-induced
tumours grew in all cases. First generation transplants often grew slowly reaching
a size of approximately 3 x 2 x 2 cm. within 4 to 6 weeks. Thereafter trans-
plants grew more rapidly although in some cases, this led to marked necrosis in
the tumours. In selecting transplanted tumour for study, only nonl-necrotic
tumour masses were taken and generally, these were from the 2nd or 3rd generation
transplants.
Sub-cellular Fractionation of Tissues
Rats were killed by cervical dislocation and the livers perfused immediately
with cold 0-15 M NaCl followed by 0*44 M sucrose. Liver or tumour tissue was
then removed and further processing carried out in the cold (2° C.). Following
mincing with scissors, tissue samples were homogenized in 0 44 AI sucrose (1 to
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2 ml./g. wet weight of tissue) in a glass Potter-Elvehjem homogenizer fitted with
a motor-driven Perspex pestle operating with a controlled clearance of 0.1 mm.
For normal liver and other soft tissue samples, homogenization was achieved
with the pestle rotating at 3000 to 5000 rev./minute. With harder tumour tissue,
greater rotational speeds up to 10,000 rev./minute were necessary to ensure
satisfactory homogenization. In all cases, however, the temperature of the homo-
genates was carefully controlled and not allowed to rise above 50 C.
Following tissue homogenization, cell fractions were isolated essentially as
described by D'Amelio and Perlmann (1960). Hence, mitochondrial supernatant
fractions were prepared by centrifugation of tissue homogenates at 20,000 g for
30 minutes. These fractions were subsequently re-centrifuged at 105,000 g for
120 minutes to sediment microsome fractions. After removal of the top half of
the supernatant (cell sap) fractions, the microsome pellets were rinsed in 0 44 M
sucrose and re-suspended in this medium. Both the cell sap and microsome frac-
tions were then re-centrifuged at 105,000 g for a further 120 minutes. The final
microsome pellets were rinsed in 0-25 M sucrose and re-suspended in this medium.
Again, only the upper half of each cell sap fraction was collected to minimize
contamination with microsomal material.
Cell sap.-Normal liver fractions prepared as above contained 15-20 mg.
protein/ml. whereas the protein content of tumour fractions was somewhat lower
(7-16 mg./ml.). Unless used immediately, fractions were stored at -20° C.
Microsomes.-Fractions suspended in 0.25 M sucrose were used directly for
immunization. For immunochemical analysis, they were solubilized in the cold
by the addition of an amount of sodium deoxycholate (5 per cent in 0-2 M glycyl-
glycine buffer, pH 8.0) equivalent to 3 the weight of microsomal protein. After
20 minutes, the deoxycholate concentration was adjusted to 0 4 per cent by the
addition of 0*25 M sucrose so that the final solutions contained approximately
6 mg./ml. of microsomal protein. These fractions were either used directly or were
further re-centrifuged at 105,000 g for 120 minutes to sediment the ribosomal
components. After removal of the upper half of the deoxycholate solubilized
fraction, the ribosomal pellet was rinsed in 0-25 M sucrose and re-suspended in
this medium. Again, unless used immediately, microsome preparations or sub-
fractions were stored at -20° C.
Preparation ofAntisera
Antigens
Normal liver microsomes.-Whole microsome fractions re-suspended in 0-25 M
sucrose so as to contain 25 to 30 mg./ml. microsomal protein. In practice, approxi-
mately 30 g. wet weight ofrat liver yielded sufficient microsomes for injection into
4 rabbits.
Normal liver cell sap.-Fractions in 0 44 M sucrose and containing 15 to 20 mg.
protein/ml. were used.
For immunization, freshly prepared liver fractions were emulsified with equal
volumes of Freund's adjuvant (complete) and used immediately. Antisera were
prepared by intramuscular injection of the Freund's adjuvant mixtures into
adult rabbits. A typical immunization schedule consisted ofthree or four injections
at 3 weekly intervals of 2 ml. Freund's adjuvant mixture; 1 ml. being adminis-
tered into each hind leg. Rabbits were bled 2 to 3 weeks after the final injection
287R. W. BALDWIN
and sera collected in the usual manner. Merthiolate was added to give a final
concentration of 0 01 per cent and antisera were stored at 20' C.
In practice, groups of 4 rabbits were immunized with cell fractions prepared
from the pooled liver of 4 rats. The final antisera were either stored individually
or pooled after their activity had been assessed by immunodiffusion analysis.
Irnmunochemical Procedures
Double diffusion analyses were carried out in 1 per cent agar gels in buffered
saline (0.15 M NaCl, 0*01 M Na phosphate, pH 7.4) containing 0-2 per cent sodium
azide as preservative. Cell sap fractions were tested directly in 0-44 M sucrose.
Similarly, analysis of microsomal antigens was carried out with preparations
solubilized in 0 4 per cent sodium deoxycholate in 0-25 M sucrose. Diffusion wells
were filled once with 0.2 ml. of each reagent and the sealed plates were incubated
at 2° C. Under these conditions, precipitation patterns usually were fully developed
within 7 to 10 days.
For inhibition studies, agar plates were prepared in which tissue fractions were
incorporated into the gel. These gels were prepared by adding the tissue fraction
rapidly with continuous gentle stirring to a one per cent agar solution in buffered
saline at 450 C. As soon as the tissue fraction was fully dispersed, agar plates were
prepared in the usual manner at room temperature and when solidified, transferred
to a cold room (2° C.) where all further manipulations were conducted.
Immunoelectrophoresis
Immunoelectrophoresis was carried out on 20 x 12 cm. glass plates coated with
a 2 mm. layer of 1 per cent agar in Veronal buffer, pH 8-6, Iu 0 025 (Grabar, 1959).
Electrophoretic separations were performed at 2° C. employing a potential gradient
of 5 volts/cm. for 3 hours. Under these conditions, a current of approximately
20 mA was required for each plate.
Before analysis, tissue fractions were equilibrated with Veronal buffer, pH 8 6,
p, 0*05 by dialysis against 50 to 100 volumes of buffer at 2° C. for 20 hours. When
necessary, precipitates were removed by centrifugation (3,000 g for 30 minutes)
and the solutions were then mixed with an equal volume of 2 per cent agar in
distilled water for insertion into agar gel plates. Following electrophoresis,
immunodiffusion patterns were developed in the usual manner (Grabar, 1959)
with incubation at 2° C. for 7 to 10 days.
Chemical Analyses
Protein was determined by the Lowry technique (Lowry, Rosebrough, Farr
and Randall, 1951) using bovine serum albumin as the primary standard.
RESULTS
Cell sap antigens
Comparison of the agar gel cross-reactions of the soluble cytoplasmic (cell sap)
fractions from normal liver (Ncs) and DMAB-induced tumour (Tcs) with rabbit
antiserum prepared against normal liver cell sap (anti-Ncs) indicates two main
features (Fig. 3, top pattern).
1. Two normal liver cell sap antigens do not cross-react with components in
the tumour fraction.
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2. One tumour antigen does not cross-react with normal liver. Since, however,
the antiserum was prepared against normal liver cell sap, this tumour component
cannot be an abnormal antigen but must be a normal liver antigen present at a
greatly increased concentration. In order to confirm the nature ofthis component,
aliquots of the anti-normal liver cell sap antiserum were pre-absorbed at 40 C. for
4 days with varying amounts of normal liver cell sap and then analysed by agar
gel diffusion. Following absorption with normal liver cell sap at a concentration
of 8 mg. protein/ml. antiserum, there was no reaction with this fraction although a
sharp precipitation line was still detectable following interaction with tumour cell
sap. Complete removal of the tumour reaction was obtained when antiserum was
absorbed with a larger amount of normal liver cell sap (32 mg. protein/ml. anti-
serum). These results demonstrate that the apparently abnormal component in
tumour is a normal liver antigen. However, consideration ofthe amount ofnormal
liver cell sap necessary to absorb antibody cross-reacting with tumour indicates
that the concentration ofthis normal liver antigen must be elevated at least 4-fold
in tumour.
In all, cell sap fractions from 17 DMAB-induced tumours have been analysed
using 6 individual and 2 pooled preparations of rabbit anti-normal liver cell sap
antiserum. Loss ofnormalliver cell sap antigen was observedin all tumourprepara-
tions. Usually two well defined normal liver antigens were deleted from tumour
(Fig. 3, top pattern), although in certain cases, the number of antigens deleted
varied from one to four Additionally, cell sap fractions from tumours induced in
4 rats with 3'-Me-DMAB were analysed. These results again demonstrated that
two normal liver cell sap antigens were deleted from tumour.
In order to showthatthe deletion ofnormal liver cell sap antigens from DMAB-
induced tumour was not due to non-specific dietary effects during carcinogen
feeding, in a number of analyses, the tumour cell sap fraction was also cross-
reacted with a similar fraction prepared from apparently healthy liver taken
from the tumour bearing rat. A typical precipitation pattern obtained with
these fractions and anti-normal liver cell sap antiserum is shown in Fig. 3 (lower
pattern). This again indicates that two antigenic components detectable in the
apparently normal liver fraction (NTLics) do not cross-react with tumour (Tcs).
Furthermore, no significant differences were detectable when normal liver cell sap
and fractions from apparently healthy liver tissue taken from tumour bearing rats
were cross-reacted with anti-normal liver cell sap antiserum.
Absorption studies
In order to ascertain whether the observed loss of liver cell sap antigens
from DMAB-induced tumour was due simply to a decrease in the concentration
of the normal liver components, attempts were made to remove antibody reacting
with normal liver cell sap by pre-absorption of antiserum with tumour cell sap.
Accordingly, aliquots ofantiserum were incubated at 40 C. for 4 days with amounts
oftumour cell sap protein ranging from 2 to 20 mg./ml. ofantiserum. Afterremoval
ofprecipitates by centrifugation, the absorbed antisera were tested against normal
liver and tumour cell sap fractions utilizing the agar gel double diffusion technique.
Although complete removal of antibody reacting with tumour cell sap was not
easily achieved, following pre-absorption of antiserum with 4 mg./ml. of tumour
protein, only one strong precipitation line together with a number of weak lines
were formed against this fraction. This antiserum still reacted strongly with normal
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liver and several well defined precipitation lines were detectable. Following absorp-
tion of antiserum with increasing amounts of tumour cell sap, the reaction detect-
able against this fraction was further diminished. Hence when treated with 16 mg.
tumour cell sap/ml. of serum, only a weak reaction was detectable with this
fraction (Fig. 4). In contrast, the absorbed serum still reacted as strongly as the
unabsorbed serum with normal liver cell sap and at least six precipitation lines
were detectable (Fig. 4).
Further evidence indicating that normal liver cell sap antigens are deleted
from tumour was obtained when the absorption of antiserum was carried out
indirectly by conducting the immunodiffusion analyses in agar gels into which
tumour cell sap had been incorporated. Providing that the agar contains a
sufficient concentration of tumour cell sap, antibody reacting with antigens in
this fraction is inhibited around the antiserum well, whilst non-reacting antibody
can diffuse out into the gel and thus is available for reaction.
The cross-reaction of normal liver and tumour cell sap fractions with an anti-
normal liver cell sap antiserum in an agar gel containing 2*4 mg./ml. of tumour
cell sap protein is illustrated in Fig. 5. With these conditions, all the antibody
reacting with tumour cell sap antigens has been inhibited around the antiserum
well. Two well defined precipitation lines were still formed, however, following
reaction with normal liver cell sap and both showed no cross-reaction with tumour.
Clearly therefore, these lines represent normal liver antigens that are absent from
tumour. In contrast incorporation ofnormal liver cell sap into agar gels at a concen-
tration of 1.4 mg. protein/ml. completely abolished the reaction of this fraction
with the homologous antiserum.
Immnunoelectrophoretic analysis
Immunoelectrophoresis allowed further resolution of normal liver cell sap
antigens and at least 20 components were detectable following interaction with
the homologous antiserum (Fig. 6). Comparison of the immunoelectrophoretic
pattern obtained with tumour cell sap clearly indicates that a number of normal
liver antigens are not detectable in tumour (Fig. 6) although the complexity of
the patterns made identification of specific lines difficult. Immunoelectrophoretic
patterns were greatly simplified however when antisera were exhaustively pre-
absorbed with tumour cell sap. This is illustrated in Fig. 7 which shows theimmuno-
electrophoretic patterns obtained with normal liver and tumour cell sap fractions
following interaction with anti-normal liver cell sap antiserum before and absorp-
tion with tumour cell sap. The precipitation pattern obtained following reaction
of normal liver cell sap with the homologous antiserum is again highly complex
although clearly, a number of these precipitation lines are not formed following
reaction with the tumour fraction. Consideration of the reactions obtained with
antiserum pre-absorbed with tumour cell sap (centre well) shows that nine
precipitation lines were detectable in normal liver cell sap. Since only a single
weak precipitation line was formed following interaction with tumour cell sap,
this indicates that at least eight normal liver cell sap antigens were missing from
the tumour fraction. Altogether, 6 DMAB-induced tumours have been analysed
immunoelectrophoretically using tumour absorbed anti-normal liver cell sap
antiserum. These analyses showed that between 5 and 8 normal liver cell sap
antigens were deleted from tumour.
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iicrosonmal antiyens
Although rabbit antisera were prepared against whole normal liver microsomes,
for immunochemical analysis, microsomal preparations were solubilized in 0-4
per cent sodium deoxycholate. This treatment, which generally is supposed to
solubilize lipoproteins of the membranes of the endoplasmic reticulum liberating
the contents of the membranous vesicles, has been claimed (D'Amelio and Perl-
mann, 1960) to be without great effect on the properties of microsomal antigens.
Because of the low yield of microsomes from DMIAB-induced liver tumour (1-2
mg./g. wet weight of tissue), these deoxycholate solubilized fractions were not
generally sub-fractionated into the soluble and ribosomal components. However,
preliminary studies demonstrated that deoxycholate solubilization yielded
fractions in which the antigenic composition was reasonably reproducible. More-
over, as shown in Fig. 8, the precipitation pattern obtained with whole solubilized
normal liver microsome fractions represented mainly interactions of the soluble
proteins (Sp) and little or no reaction was produced by either the ribosomal (Rp)
or membranous (Mm) components at the concentrations contained in the whole
fraction.
A typical cross-reaction pattern obtained following agar gel double diffusion
analysis of deoxycholate solubilized microsome fractions of normal liver (N mic)
and DMAB-induced tumour (T mic) with anti-normal liver microsome antiserum
(anti-N mic) is shown in Fig. 9 (top pattern). This demonstrates quite clearly
that two major antigenic components of normal liver microsomes do not cross-
react with tumour. Additionally, a third poorly defined precipitation band
formed near to the well containing normal liver microsomes does not show any
obvious cross-reaction with tumour. In contrast, no differences were detectable in
the cross-reaction pattern obtained with a microsome fraction from normal liver
and a similar fraction prepared from apparently healthy liver tissue taken from
the tumour bearing rat (N TLi mic). Thus, as shown in Fig. 9 (lower pattern),
the two major and one weaker lines which were not formed against tumour were
detectable in both liver fractions. This demonstrates that the deletion of normal
liver microsomal antigen observed in DMAB-induced tumour was not due to non-
specific effects during carcinogen administration.
In all, the antigenic composition of 15 tumour microsomal fractions, each of
which was prepared from pooled tumour tissue taken from 2 to 4 rats, have been
compared with that of normal liver microsomes using 5 individual and one pooled
sample (4 rabbits) of anti-normal liver microsome antiserum. Loss of normal
liver microsomal antigen from tumour was observed in all the analyses, although
the number of components deleted showed some variation. This most probably
was due to poor resolution of deoxycholate solubilized microsomal components
by simple diffusion. Hence in a number of analyses, the normal liver component
not cross-reacting with tumour was detected as a single dense precipitation line
and this most likely represented poor resolution ofthe two normal liver lines shown
in Fig. 9 (top pattern).
Loss of normal liver microsomal antigen was also observed in two tumours
induced with 3'-methyl-DMAB. Moreover, it was shown that transplants of one
DMAB-induced tumour were also deficient in certain normal liver microsomal
antigens. This is illustrated in Fig. 10 which shows the cross-reaction pattern of
microsome fractions from normal liver (N mic) and from a 3rd generation trans-
-)9R. W. BALDWIN
plant of a DMAB-induced tumour (T/3 mic) with anti-normal liver microsome
antiserum. Thus, as with the primary iDMAB-induced tumour, two major precipi-
tation lines together with a third more diffuse line formed with normal liver do
not cross-react with components in the transplanted tumour.
EXPLANATION OF PLATES
FIG. 1. Section of liver tumour showing pleomorphic acinar proliferation. The lining cells
vary from columnar to flat cuboidal in type. Most of the acini contain necrotic cellular
debris, but a few contain mucoid material. There are areas of necrosis in some parts of the
tumour.
FIG. 2. Section of liver tumour consisting of solid cords of cells which have large nuclei, many
showing mitotic figures. There are surrounding zones of necrosis and polymorph infiltra-
tion but very little evidence of acinar formation.
FIG. 3. Agar gel precipitation reaction of tissue cell sap fractions with antiserum prepared
against normal rat liver cell sap (anti-N.cs).
Ncs Normal liver cell sap.
Tcs DMAB-induced tumour cell sap.
NTLics Cell sap fraction of liver taken from tumour bearing rat.
All cell sap fractions contained 13-7 mg. protein/ml.
FIG. 4.-Cross-reaction in agar of normal liver and tumour cell sap fractions with anti-
normal liver cell sap antiserum pre-absorbed with tumour cell sap (16 mg. protein/ml.).
See Fig. 3 for legends. Protein content of cell sap fractions, 11 mg. /ml.
FIG. 5. Precipitation reactions of normal liver and tumour cell sap fractions (protein content, 11 mg./ml.) with anti-normal liver cell sap antiserum in agar gel containing tumour cell sap
(2-4 mg. protein/ml.). See Fig. 3 for legends.
FIG. 6. Immunoelectrophoresis ofnormal liver and tumour cell sap fractions (protein content,
8-9 mg./ml.). See Fig. 3 for legends.
FIG. 7. Comparison of the immunoelectrophoretic patterns obtained following reaction of cell
sap fractions with anti-normal liver cell sap antiserum (anti Ncs) before and after absorption
with tumour cell sap (Tcs).
FIG. 8. Agar gel precipitation reactions of deoxycholate solubilized normal liver microsomes
and sub-fractions with anti-normal liver microsome antiserum (anti Nmic).
Mic.-Whole microsome fraction solubilized in 0-4 per cent sodium deoxycholate (6 mg.
protein/ml.).
Sp.-Soluble fraction of whole microsomes in 0-4 per cent deoxycholate (5 mg. protein/ ml.).
Rp. Ribonucleoprotein fraction re-suspended in 0-25 M sucrose at a concentration
equivalent to that in the whole microsome fraction (0* 4 mg. protein/ml.).
MM. Fluffy layer isolated from above Rp pellet on centrifugation of deoxycholate
solubilized microsomes and re-suspended in 0-25 M sucrose at its original concentration (0
-7 mg. protein/ml.).
FIG. 9.-Agar gel precipitation patterns of deoxycholate solubilized microsome fractions
from normal liver and DMAB-induced tumour with anti-normal liver microsome antiserum
(anti-N mic).
N mic Normal liver microsomes.
T mic-DMAB-tumour microsomes.
N.T.Li mic Microsome fraction of liver taken from tumour bearing rat.
Protein content of microsome fractions, 6-7 mg./ml.
FIG. 10. Agar gel cross-reaction pattern of deoxycholate solubilized microsome fractions of
normal liver and a 3rd generation transplant of a DMAB-induced liver tumour with anti-
normal microsome antiserum (anti N mic).
N mic Normal liver microsome, DOC solubilized (6-7 mg. protein/ml.).
T/3 mic Microsome fraction from 3rd generation transplant of DMAB-induced tumour,
DOC solubilized (6 mg. protein/ml.).
FIG. 11.-Immunoelectrophoresis of deoxycholate solubilized microsome fractions of normal
liver and DMAB-induced tumour.
Normal liver N mic (Doc sol.) (3-2 mg. protein/ml.).
DMAB-tumour-T mic (Doc. sol.) (3-0 mg. protein/ml.).
Antiserum-anti-normal liver microsome (anti-N mic).
FIG. 12. Immunoelectrophoresis of microsome fractions utilizing anti-normal liver microsome
antiserum pre-absorbed with tumour microsomes (see Fig. 11 for legends).
Protein content of microsome fractions 5-6 mg./ml.
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Absorption studies
In order to confirm that normal liver microsomal antigens were deleted fromn
LD)MAB-induced tumour, attempts were made to remove antibody reacting with
these liver antigens by pre-absorption of antiserum with tumour microsomes.
Thus aliquots of an anti-normal liver microsome antiserum were treated at 4° C.
for 4 days with varying amounts of tumour microsomal protein. After removal of
the precipitates by centrifugation, the absorbed sera were then tested against
normal liver and tumour microsome fractions using the agar gel diffusion tech-
nique. As shown in Table I, absorption with tumour microsomes at a concentration
TABLE I. Absorption of Anti-Normal Liver Microsome Antiserum with
Deoxycholate Solubilized Tumour Microsomes
Absorption conditions:
Amount of tumour microsomal
Number of precipitation protein. mg./ml. antiserum
lines formed following -
reaction with 0 1-5 3 0 4-5 6-0
Normal liver microsomes 5 3 2 2 2+1
weak
Tumour microsornes . 2-3 1 0 0 1 weak
of 1P5 mg./ml. of antiserum almost completely removed antibody reacting with
this fraction and only a single weak line was detectable. This reaction line was
completely removed following absorption with 3 mg. tumour microsomal
protein/ml. antiserum and in this case it was shown also that the absorbed anti-
serum contained slight excess of tumour antigens. Two strong precipitation lines
were still detectable following interaction with a normal liver microsome fraction.
These lines were unaffected even when the antiserum was absorbed with up to
6 mg./ml. of tumour microsome protein. In this case, however, a third weak
component was detectable in both normal liver and tumour fractions. This most
probably was due to non-precipitation of some antigen-antibody complexes
during absorption because of great excess of absorbing antigen.
Immunoelectrophoretic analysis
For immunoelectrophoresis, it was necessary to equilibrate deoxycholate
solubilized microsome fractions against Veronal buffer, pH 8.0, ,u, 0 05. However,
little or no precipitate was formed following dialysis of fractions for 20 hours at
2° C. against 50 to 100 volumes of buffer and the final samples were analysed at a
concentration of 3 to 7 mg./ml. of microsomal protein. Immunoelectrophoresis
was carried out for 3 hours with a potential gradient of approximately 5 volts/cm.
Under these conditions, the major antigenic fraction migrated 2-3 cm. towards
the cathode and as shown in Fig. 11 permitted the detection of at least 10 compo-
nents reacting with anti-normal liver microsome antiserum. Precise evaluation of
the number of components was difficult since a band containing the major anti-
genic fraction was not well resolved. However, compared with the precipitation
pattern obtained with the tumour microsome fraction (Fig. 11), it is obvious that a
number of antigenic components detectable in the major band are deleted from
tumour.
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In order to further define the normal liver microsomal antigens that are deleted
from tumour, immunoelectrophoretic analyses were also carried out using anti-
normal liver microsome antiserum which had been exhaustively pre-absorbed
with a deoxycholate solubilized tumour microsome fraction. As shown in Fig. 12
this antiserum no longer reacted with the tumour microsome fraction. In contrast,
a major band containing at least 3 components and two further well defined lines
were formed following interaction with the normal liver microsome fraction.
Additionally a group of at least four poorly resolved lines were detectable close
to the well containing antigen. Hence whilst the conditions of electrophoresis are
not entirely satisfactory for characterization of liver microsomal antigens, this
procedure permits the detection of at least 10 normal liver microsomal antigens
which are deleted from DMAB-induced tumour.
DISCUSSION
Loss of normal liver microsomal antigen from DMAB-induced tumour has
been demonstrated by Weiler (1956) and Nairn et al. (1960) using immunohisto-
logical procedures. Similarly Hiramoto et al. (1961) showed that liver tumours
induced with 2-acetylaminofluorene did not stain with antisera prepared against
normal liver microsomes. That normal liver microsomal antigens are deleted from
DMAB-induced tumour has been confirmed in the present studies whilst applica-
tion of immunodiffusion techniques has allowed some characterization of the
antigens involved. Direct cross-reaction of deoxycholate solubilized microsome
fractions with anti-normal liver microsome antiserum also indicated that there
are a number of antigenic components common to both normal liver and tumour.
This is hardly surprising considering that liver microsomes probably contain many
antigenic structures and it is unlikely that all ofthese would be deleted or modified
following neoplastic change. These results indicate, however, serious limitations
in the application ofthe immunohistological technique for assessing antigenic loss,
since previous studies failed to detect these weak common antigens.
Whilst direct agar gel diffusion studies indicated that certain components in
deoxycholate solubilized fractions of tumour microsomes did not cross-react with
normal liver it is possible that this was due to quantitative rather than qualitative
modifications. However, antibody reacting with the normal liver antigens which
were not detectable in tumour could not be removed by pre-absorption of anti-
serum with tumourmicrosomes. Hence, although thepossibilitythat trace amounts
ofnormal liver microsomal antigens are present cannot be excluded, it is considered
that the loss of reaction with tumour represents antigen deletion.
Antigen deletion in DMAB-induced tumour was not limited to microsomal
components alone, and significant losses were observed also in the cell sap antigens
(Fig. 3). Again absorption studies demonstrated that antigen deletion in tumour
was not due simply to quantitative losses of the normal liver components.
Additionally immunoelectrophoretic analysis of normal liver cell sap fractions
using homologous antiserum pre-absorbed with tumour allowed partial charac-
terization of the antigens involved and indicated that at least five components
are deleted from tumour. Clearlytherefore, a complex series ofcell antigen changes
occurs during aminoazo dye carcinogenesis in rat liver resulting in the deletion of
liver microsomal and cell sap antigens from tumour. Additionally, the concen-
tration of one normal liver cell sap antigen was increased at least 4-fold in tumour.
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Loss of liver antigen from DMAB-induced hepatoma has been reported also
by Kalnins and Stich (1963) although since antisera were prepared against whole
liver homogenates, identification of the deleted antigens was not possible. It was
reported, however, that individual hepatomas differed in the number of antigens
lost. Deckers (1963) has also demonstrated that liver microsomal antigen was
deleted from a transplanted rat hepatoma, whilst Friedrich-Freksa (1963) has
partially purified and characterized one of the liver microsomal antigens that are
missing from DiIAB-induced tumour. These findings, together with the extensive
investigations of Abelev and co-workers using o-aminoazotoluene induced hepa-
tomas in mice (Abelev, Avenirova, Engelhardt, Baydakova and Stepanchemok-
Rudnik, 1959; Abelev, Khramkova and Postnikova, 1962; Abelev, 1963) thus
present an extensive body of evidence demonstrating that cell antigens are
deleted from aminoazo dye induced liver tumour.
In considering the significance of the loss of normal liver cell antigens from
IDMAB-induced tumour, the possibility needs to be considered that the changes
simply reflect alterations in cell populations. Thus liver contains at least three
types of cells each of which may possess its own antigenic characteristics. In
consequence antigen deletion may not be due to alterations in the antigenic
composition ofthe neoplastic cell, but might for instance be due to gross alterations
in the proportions of normal cells.
A common form of neoplasm encountered in the present investigation has
been that of bile duct origin. Hence it may be argued that with these tumours,
loss of antigens was due to replacement of normal liver cells by bile duct cells.
However, if this were so, gradual deletion of cell antigens should occur during the
earlier stages of aminoazo dye carcinogenesis when there is considerable prolifera-
tion ofbile duct cells (Daoust and Cantero, 1959) with concomitant losses ofhepatic
enzymes (Jones, 1963), but such changes have not been observed. Moreover studies
oII the proportion of various cell types in liver during DMAB carcinogenesis
(Daoust andCantero, 1959) indicate that these variations are probably not sufficient
to account for the observed loss of cell antigens in tumour. Other tumours used
in these studies showed the histological characteristics of true hepatocarcinoma
and significantly, these also proved to be deficient in certain normal liver antigens.
In view of the wide diversity of neoplastic cell types, it is perhaps surprising that
the differences observed between the antigenic composition of normal and tumour
cell fractions was so reproducible. It is possible however that the procedures
used for resolving tissue antigens were imprecise and individual differences may
be detected with more refined techniques. Moreover, the requirement for rela-
tively large samples of tumour tissue results in an increased complexity of types
of cells involved, so that individual differences between tumours may be obscured.
Hence a more critical assessment of the significance of cell antigen changes in
DMAB-carcinogenesis should be obtained from immunohistological studies using
monospecific antisera against purified normal liver antigens which the present
studies indicate to be deleted from tumour. Additionally however, the possi-
bility that liver cell and bile duct tumours have common antigenic structures
needs to be considered, particularly in view of the suggestion that such tumours
have a common origin in a primitive hepatic cell (Maisin, Lambert, Deckers-
Passau, and Maldague, 1957).
In order to ascertain the significance of cell antigen deletions in DMIAB
carcinogenesis, it is clearly important to discover the physiological role of these
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antigens. Only then will it be possible to decide whether the antigenic changes
are causally connected with the neoplastic transformation or simply are alternative
expressions of biochemical change. The major problem however is to devise
possible methods for assaying purified tissue antigens since characterization in
biochemical terms such as enzyme content may not be relevant. Thus although
Friedrich-Freksa (1963) has partially purified a microsomal antigen which is
deleted from DMAB-induced tumour, its physiological action is still unknown
beyond the finding that it contains glucose-6-phosphatase activity. According
to Green (1954) the essential change in the neoplastic cell is the loss of a tissue
specific factor (antigen) which is considered to be located in the endoplasmic
reticulum. Similarly, Burch (1963) from theoretical considerations ofmechanisms
ofcarcinogenesis has postulated that the critical change is the removal or alteration
of a microsomal "differentiating factor ". That tissue controlling factors exist
is clearly demonstrated in the studies of Bullough (1962) on substances (chalones)
which control the mitotic activity of mouse epidermis and so the possibility that
the normal liver microsomal antigens deleted from tumour possess growth
controlling properties clearly requires further investigation. Whilst generally
it has been assumed that modification of microsomal antigen represents the critical
deletion in carcinogenesis, the present studies also indicate that liver cell sap
antigens are missing from DMAB-induced tumour. The nature and function of
these cell sap antigens also requires investigation particularly in view ofthe sugges-
tion (Burwell, 1963) that soluble tissue factors may be responsible for growth
control of many differentiated tissues. Moreover, Bullough (1962) has shown
that at least part of the epidermis-specific mitotic inhibitor (chalone) is water
soluble.
According to the immunological concept of carcinogenesis, loss of cell antigen
in the neoplastic cell occurs as a consequence of an immune response to modified
tissue antigens. The finding that abnormal tissue antigens are formed as a
result of covalent bonding of a metabolite of DMAB to liver protein (Baldwin,
1962a) lends support for such an hypothesis. Moreover it has been shown that
liver antigens are liberated and circulate in the blood stream following induction
of acute liver damage with nitroso-dimethylamine and other hepatotoxic agents
(Baldwin, 1962b). Hence it is also likely that the abnormal DMAB-antigens
will be liberated during carcinogenesis and so will be available for the induction of
an immune response. Whilst such an immune response has still to be demon-
strated, it is perhaps relevant that liver autoantibody has been detected in rat
serum following induction of liver damage with carbon tetrachloride (Weir, 1963).
Possible mechanisms whereby an immune response to modified tissue antigens
could effect the neoplastic change are more difficult to conceive. However,
Burch (1963) has suggested that the modified cell antigen is a lipoprotein compo-
nent ofthe cell membrane and endoplasmic reticulum which normally is the source
ofone or more factors that combine with or affect repressor molecules to determine
the differentiation state of the cell and its overall metabolic pattern. Hence if
antibody blocked or deleted such antigenic structures, this could lead to an
irreversible change in the resulting neoplastic cell.
Whilst the present findings have been interpreted within the framework of
the immunological concept of carcinogenesis, other interpretations are clearly
possible. Thus, for example, antigen deletion may simply reflect mutational
changes induced by the carcinogen. These interpretations, however, permit the
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design of further experiments which should allow a critical evaluation of the role
of tissue immune reactions in chemical carcinogenesis.
SUMMARY
Modifications in the antigenic composition of sub-cellular fractions of rat liver
during aminoazo dye carcinogenesis have been investigated. Normal rat liver
cell sap antigens were found to be deleted from DMAB-induced liver tumour and
partial characterization ofthese antigens was obtained by immunoelectrophoresis.
Additionally, the concentration of one normal liver cell sap antigen was shown to
be increased at least 4-fold in tumour. Loss of normal liver microsomal antigen
from DMAB-induced tumour was also demonstrated and the deleted antigens
characterized by immunoelectrophoresis.
No differences were detectable between the antigenic composition of cell
fractions fromnormalliverandapparentlyhealthylivertakenfromtumour-bearing
rats. It was concluded therefore that loss of cell antigens from tumour occurred
as a result of neoplastic change rather than from non-specific effects during
carcinogen feeding.
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